Literature DB >> 2447503

Subcellular fractionation of dystrophin to the triads of skeletal muscle.

E P Hoffman1, C M Knudson, K P Campbell, L M Kunkel.   

Abstract

Duchenne muscular dystrophy (DMD) is a human X-linked biochemical defect resulting in the progressive wasting of skeletal muscle of affected individuals. It is the most common and is considered to be the most devastating of the muscular dystrophies, affecting about 1 in 3,500 live-born males. The gene that, when defective, results in this disorder was recently isolated. Using the cloned complementary DNA sequences corresponding to the DMD gene, antibodies have been produced that react with a protein species of relative molecular mass (Mr) approximately 400,000 (400K) which was absent in two DMD-affected individuals and in mdx mice. This protein species is called dystrophin because of its identification by molecular-genetic analysis of affected individuals. Here we show that dystrophin is associated with the triadic junctions in skeletal muscle, and is therefore probably involved with Ca2+ homoeostasis. We also show that the approximately 450K ryanodine receptor/sarcoplasmic reticulum Ca2+ channel, which has the large size and subcellular distribution characteristics of dystrophin, is an immunologically distinct protein species.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2447503     DOI: 10.1038/330754a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  68 in total

1.  Intracellular calcium signals measured with indo-1 in isolated skeletal muscle fibres from control and mdx mice.

Authors:  C Collet; B Allard; Y Tourneur; V Jacquemond
Journal:  J Physiol       Date:  1999-10-15       Impact factor: 5.182

Review 2.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

3.  Isolated dystrophin molecules as seen by electron microscopy.

Authors:  F Pons; N Augier; R Heilig; J Léger; D Mornet; J J Léger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 4.  Molecular genetics of mineral metabolic disorders.

Authors:  R V Thakker
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 5.  Gene mapping of mineral metabolic disorders.

Authors:  R V Thakker; K E Davies; J L O'Riordan
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

6.  2004 William Allan Award address. Cloning of the DMD gene.

Authors:  Louis M Kunkel
Journal:  Am J Hum Genet       Date:  2005-02       Impact factor: 11.025

7.  The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies.

Authors:  Mahmoud R Hussein; Sherifa A Hamed; Mohammed G Mostafa; Eman E Abu-Dief; Nageh Fouly Kamel; Mahmoud R Kandil
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

8.  Cytoskeletal tropomyosin Tm5NM1 is required for normal excitation-contraction coupling in skeletal muscle.

Authors:  Nicole Vlahovich; Anthony J Kee; Chris Van der Poel; Emma Kettle; Delia Hernandez-Deviez; Christine Lucas; Gordon S Lynch; Robert G Parton; Peter W Gunning; Edna C Hardeman
Journal:  Mol Biol Cell       Date:  2008-11-12       Impact factor: 4.138

9.  Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice.

Authors:  O Friedrich; M Both; J M Gillis; J S Chamberlain; R H A Fink
Journal:  J Physiol       Date:  2003-10-31       Impact factor: 5.182

10.  Duplication detection in Japanese Duchenne muscular dystrophy patients and identification of carriers with partial gene deletions using pulsed-field gel electrophoresis.

Authors:  M Kodaira; K Hiyama; T Karakawa; H Kameo; C Satoh
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.